Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder of the company, is planning to transfer 23.43% of the company's shares through public solicitation of transferees. After the transfer is completed, Zhongheng Group will no longer directly hold the company's shares; it will only hold 2.03% of the shares indirectly through its holding subsidiary. If this transfer is completed, the controlling shareholder and actual controller of the company will change.

Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder of the company, is planning to transfer 23.43% of the company's shares through public solicitation of transferees. After the transfer is completed, Zhongheng Group will no longer directly hold the company's shares; it will only hold 2.03% of the shares indirectly through its holding subsidiary. If this transfer is completed, the controlling shareholder and actual controller of the company will change.